Shared Decision Making Interventions for Deprescribing in Older Adults With Polypharmacy: A Scoping Review
- 29 August 2025
- journal article
- review article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 73 (12) , 3884-3894
Abstract
Background: Despite being integral to the deprescribing process, integration of shared decision making (SDM) into structured deprescribing interventions and its relation to patient outcomes remain understudied. Methods: We conducted a scoping review of PubMed/MEDLINE, Embase, Scopus, and PsycInfo (through September 2023) with a medical librarian's guidance. Studies of SDM interventions for deprescribing in older adults with polypharmacy were included. Two independent reviewers performed screening and data abstraction. An iterative narrative synthesis was conducted to categorize the core functions (purposes) and forms (specific activities) of the identified interventions, along with their measured outcomes, including SDM‐related outcomes. Results: Among 5402 retrieved records, 14 studies of 12 distinct interventions met the inclusion criteria. Studies were published between 2017 and 2023 and described a pilot implementation ( n = 3), randomized controlled trials ( n = 9), or patient interviews assessing perceptions regarding interventions ( n = 2). Most interventions ( n = 9) evaluated were specific to the outpatient setting and led by primary care physicians ( n = 6) or pharmacists ( n = 3). Two ( n = 2) were hospital‐based, involving pharmacists with nurse practitioners or physicians, and one ( n = 1) took place in nursing homes, led by nurses. Along with patient and medication identification ( n = 12) and SDM ( n = 12), common core functions included decision support ( n = 7), care coordination ( n = 5), coordinating follow‐up and monitoring ( n = 3), and family/caregiver involvement ( n = 2). Only 4 studies explicitly mentioned an SDM framework, the Three‐Talk Model ( n = 2), AHRQ SHARE ( n = 1), and the Collaborative Deliberation Model ( n = 1); only three ( n = 3) explicitly measured whether SDM occurred. The majority reported positive associations between the SDM interventions and medication use ( n = 6) and deprescribing behaviors ( n = 8). Conclusions: There is substantial variability in how deprescribing interventions incorporate SDM. Most studies do not empirically measure SDM. While SDM is associated with improved satisfaction and process of care outcomes, evidence regarding the impact of SDM‐informed deprescribing interventions and patient behavioral and health outcomes is inconclusive.Keywords
This publication has 66 references indexed in Scilit:
- Effectiveness of Bundled Hyperpolypharmacy Deprescribing Compared With Usual Care Among Older AdultsJAMA Network Open, 2023
- MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General PracticeDrugs & Aging, 2021
- Core Functions and Forms of Complex Health Interventions: a Patient-Centered Medical Home IllustrationJournal of General Internal Medicine, 2019
- Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older AdultsJAMA, 2018
- Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in EuropeArchives of Gerontology and Geriatrics, 2018
- Reducing Inappropriate PolypharmacyJAMA Internal Medicine, 2015
- Use of Medications of Questionable Benefit in Advanced DementiaJAMA Internal Medicine, 2014
- Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 2012
- A Drug Burden Index to Define the Functional Burden of Medications in Older PeopleArchives of internal medicine (1960), 2007
- A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validityJournal of Clinical Epidemiology, 1994